Vehicle-mounted UHF CB radios benefit greatly from being wired up to a larger antenna (more on antennas later), which greatly increases range and use ... An easy way to think of this is to imagine a ...

Its Achilles’ heel, however, is its limited 140-150 mile range, which requires planning ... from its personalized color scheme to the CB radio that kept him connected to Graceland.

There were huge C&A stores across Essex, particularly in Chelmsford, Southend, Colchester, Basildon and Lakeside, all known ...

Already facing significant headwinds, VW has now been hit by a data protection nightmare. Location data from 800,000 electric ...

The Indiana-based firm acquired the healthcare facilities to expand its nursing home portfolio across the Midwest. ( Kansas ...

There was a time when one of the perks of having a ham radio in your car (or on your belt ... So he offered the “PocketCom CB” which was billed as the “world’s smallest citizens band ...

CB-010, a clinical-stage allogeneic anti-CD19 CAR-T cell therapy for lupus Caribou expanded the CB-010 program following clearance of its Investigational New Drug (IND) application by the U.S ...

CB radios can provide a meands of communication in remote areas where cell service may be unreliable or nonexistent. While they have a limited range and mountains and other obstructions that can ...

To see if CB-010 as an allogeneic CAR-T can help treat these patients with relapsed/refractory B-cell Non-Hodgkin Lymphoma [r/r B-NHL], it is in the process of running the phase 1 ANTLER study.

we plan to initiate a pivotal Phase 3 trial for CB-010 in second-line large B cell lymphoma in the second half of 2025. We are excited to be on the forefront of a new era for allogeneic CAR-T cell ...

that indicated a single dose of CB-010 has the potential to be on par with the safety, efficacy, and durability of approved autologous CAR-T cell therapies. A retrospective analysis of all patient ...

CB-012, a clinical-stage allogeneic anti-CLL-1 CAR-T cell therapy for acute myeloid leukemia The FDA granted Fast Track and Orphan Drug designations to CB-012 for relapsed or refractory acute ...